ETHNOPHARMACOLOGICAL RELEVANCE: HLXL is a traditional Chinese medicine that has long been used in folk medicine for the treatment of chronic inflammatory diseases. However, the precise immunological mechanisms by which HLXL mediates its anti-inflammatory activity are not fully defined. AIM OF THE STUDY: To determine the effects of HLXL on antigen-specific immune parameters in adjuvant-induced inflammation model in the Lewis rat. MATERIALS AND METHODS: Rats were fed daily with either HLXL (2.3g/kg) or vehicle (water) beginning 3 days before subcutaneous injection of heat-killed Mycobacterium tuberculosis H37Ra (Mtb), and then continued for another 6 days. After 9 days of Mtb injection, the draining lymph node cells were tested for T cell proliferative and cytokine responses against mycobacterial heat-shock protein 65 (Bhsp65). Moreover, sera were tested for anti-Bhsp65 antibodies and nitric oxide (NO). RESULTS: HLXL-treated rats showed reduced T cell proliferative response to Bhsp65 compared to control rats. Furthermore, HLXL suppressed IL-17 response but enhanced IL-10 response without much effect on IFN-gamma. HLXL treatment also reduced the levels of anti-Bhsp65 antibodies but not that of NO. CONCLUSIONS: HLXL feeding modulated both the cellular and the humoral immune response to Bhsp65 favoring an anti-inflammatory milieu for the suppression of adjuvant-induced inflammation.
ETHNOPHARMACOLOGICAL RELEVANCE: HLXL is a traditional Chinese medicine that has long been used in folk medicine for the treatment of chronic inflammatory diseases. However, the precise immunological mechanisms by which HLXL mediates its anti-inflammatory activity are not fully defined. AIM OF THE STUDY: To determine the effects of HLXL on antigen-specific immune parameters in adjuvant-induced inflammation model in the Lewis rat. MATERIALS AND METHODS:Rats were fed daily with either HLXL (2.3g/kg) or vehicle (water) beginning 3 days before subcutaneous injection of heat-killed Mycobacterium tuberculosis H37Ra (Mtb), and then continued for another 6 days. After 9 days of Mtb injection, the draining lymph node cells were tested for T cell proliferative and cytokine responses against mycobacterial heat-shock protein 65 (Bhsp65). Moreover, sera were tested for anti-Bhsp65 antibodies and nitric oxide (NO). RESULTS:HLXL-treated rats showed reduced T cell proliferative response to Bhsp65 compared to control rats. Furthermore, HLXL suppressed IL-17 response but enhanced IL-10 response without much effect on IFN-gamma. HLXL treatment also reduced the levels of anti-Bhsp65 antibodies but not that of NO. CONCLUSIONS:HLXL feeding modulated both the cellular and the humoral immune response to Bhsp65 favoring an anti-inflammatory milieu for the suppression of adjuvant-induced inflammation.
Authors: Rui-Xin Zhang; Arthur Yin Fan; An-Nan Zhou; Kamal D Moudgil; Zhong-Ze Ma; David Yue-Wei Lee; Harry H S Fong; Brian M Berman; Lixing Lao Journal: J Ethnopharmacol Date: 2008-11-28 Impact factor: 4.360
Authors: L Lao; M Hochberg; D Y W Lee; A M K Gilpin; H H S Fong; P Langenberg; K Chen; E K Li; L S Tam; B Berman Journal: Osteoarthritis Cartilage Date: 2015-06-20 Impact factor: 6.576
Authors: Ying-Hua Yang; Rajesh Rajaiah; David Y-W Lee; Zhongze Ma; Hua Yu; Harry H S Fong; Lixing Lao; Brian M Berman; Kamal D Moudgil Journal: Evid Based Complement Alternat Med Date: 2010-10-19 Impact factor: 2.629
Authors: Shivaprasad H Venkatesha; Rajesh Rajaiah; Brian M Berman; Kamal D Moudgil Journal: Evid Based Complement Alternat Med Date: 2010-12-22 Impact factor: 2.629
Authors: Siddaraju M Nanjundaiah; David Y-W Lee; Brian M Berman; Kamal D Moudgil Journal: Evid Based Complement Alternat Med Date: 2013-05-16 Impact factor: 2.629
Authors: Hua Yu; David Y-W Lee; Siddaraju M Nanjundaiah; Shivaprasad H Venkatesha; Brian M Berman; Kamal D Moudgil Journal: Evid Based Complement Alternat Med Date: 2013-07-30 Impact factor: 2.629